
Schneeberger
Facing ongoing competitive pressures and market growth demands, life science and biomedical original equipment manufacturers (OEMs) must constantly deliver new advancements in technology, processes, workflows, and production. But in addition to pursuing improvements that focus on expanding success, OEMs must also ensure against the in-use failures of their advanced equipment.
In the case of advanced instruments used in research, scientific, medical, and other critical applications, neglecting improvements and safeguards in one seemingly minor component – in-process linear motion systems – can generate consequences ranging from inconvenient to catastrophic.
This white paper highlights how next-generation linear motion systems can be specified, designed, installed, and maintained to both advance life science and biomedical capital equipment manufacturing – and ensure against failures of any consequence.
Latest from Today's Medical Developments
- From classroom to factory: A STEM collaboration that inspires
- Maximize efficiency with customizable Jergens tooling columns
- Cirtec Medical's growth promises faster, cost-effective solutions for customers
- Revolutionizing automation: Creform's made in the USA AGVs
- #64 - Manufacturing Matters: Automation offerings with Visual Components
- Insight Surgery expands U.S. presence with new manufacturing facilities
- Is your shopfloor connected? The importance of Industry 4.0 in manufacturing
- Okuma: Extraordinary Starts Where Limits End